|
|
Volumn 3, Issue 4, 2003, Pages 391-395
|
|
Spotlight on new anti-inflammatory drug targets in the immune system
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFLAMMATORY AGENT;
CALCINEURIN;
CELECOXIB;
CETIRIZINE;
CYCLOOXYGENASE 1;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITOR;
CYCLOSPORIN A;
CYTOKINE;
DICLOFENAC;
ETANERCEPT;
FEXOFENADINE;
GLUCOCORTICOID;
GLUCOCORTICOID RECEPTOR;
HISTAMINE H1 RECEPTOR;
INFLIXIMAB;
INOSINATE DEHYDROGENASE;
INTERLEUKIN 1 RECEPTOR;
LEUKOTRIENE RECEPTOR;
LORATADINE;
MONTELUKAST;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PHOSPHATIDYLINOSITOL 3 KINASE;
PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR;
PROTEIN KINASE INHIBITOR;
ROFECOXIB;
TOLL LIKE RECEPTOR;
TUMOR NECROSIS FACTOR;
TUMOR NECROSIS FACTOR ALPHA;
UNINDEXED DRUG;
ALLERGY;
APOPTOSIS;
ASTHMA;
AUTOIMMUNE DISEASE;
CELLULAR IMMUNITY;
CROHN DISEASE;
DRUG EFFICACY;
DRUG POTENCY;
DRUG TARGETING;
EDITORIAL;
ENTERITIS;
HUMAN;
IMMUNE RESPONSE;
IMMUNE SYSTEM;
INFLAMMATION;
INFLAMMATORY CELL;
INSULIN DEPENDENT DIABETES MELLITUS;
MULTIPLE SCLEROSIS;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONHUMAN;
PATHOGENESIS;
PRIORITY JOURNAL;
PSORIASIS;
RHEUMATOID ARTHRITIS;
SEPSIS;
SIDE EFFECT;
SIGNAL TRANSDUCTION;
SYSTEMIC LUPUS ERYTHEMATOSUS;
TH1 CELL;
TH2 CELL;
TREATMENT PLANNING;
ADJUVANTS, IMMUNOLOGIC;
ANIMALS;
ANTI-INFLAMMATORY AGENTS;
DRUG DESIGN;
GENE EXPRESSION REGULATION;
GLUCOCORTICOIDS;
HUMANS;
IMMUNE SYSTEM;
IMMUNITY, NATURAL;
INFLAMMATION;
MEMBRANE GLYCOPROTEINS;
RECEPTORS, CELL SURFACE;
TOLL-LIKE RECEPTORS;
|
|
EID: 0042303835
PISSN: 14714892
EISSN: None
Source Type: Journal
DOI: 10.1016/S1471-4892(03)00085-7 Document Type: Editorial |
|
Times cited : (4)
|
|
References (3)
|
